APPLICATION
ANDA065511
TYPE
ANDA
ORIGINAL APPROVAL
2009-06-26
LATEST ACTION
2020-01-27
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
AZITHROMYCINDiscontinued
AZITHROMYCIN EQ 500MG BASE/VIAL · INJECTABLE · INJECTION
Approval history
2020-01-27Labeling · Supplement 6 · standardAP
2020-01-27Labeling · Supplement 10 · standardAP
2020-01-27Labeling · Supplement 7 · standardAP
2015-02-12Labeling · Supplement 3 · standardAP
2015-02-12Labeling · Supplement 4 · standardAP
2012-10-11Labeling · Supplement 2 · standardAP
2009-06-26OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.